Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

More prominent muscle involvement in patients with dermatomyositis with anti-Mi2 autoantibodies.

Pinal-Fernandez I, Mecoli CA, Casal-Dominguez M, Pak K, Hosono Y, Huapaya J, Huang W, Albayda J, Tiniakou E, Paik JJ, Johnson C, Danoff SK, Corse AM, Christopher-Stine L, Mammen AL.

Neurology. 2019 Oct 8. pii: 10.1212/WNL.0000000000008443. doi: 10.1212/WNL.0000000000008443. [Epub ahead of print]

PMID:
31594859
2.

PTEN loss mediates clinical cross-resistance to CDK4/6 and PI3Kα inhibitors in breast cancer.

Costa C, Wang Y, Ly A, Hosono Y, Ellen M, Walmsley CS, Huynh T, Healy C, Peterson R, Yanase S, Jakubik CT, Henderson LE, Damon LJ, Timonina D, Sanidas I, Pinto CJ, Mino-Kenudson M, Stone JR, Dyson NJ, Ellisen LW, Bardia A, Ebi H, Benes CH, Engelman JA, Juric D.

Cancer Discov. 2019 Oct 8. pii: CD-18-0830. doi: 10.1158/2159-8290.CD-18-0830. [Epub ahead of print]

PMID:
31594766
3.

A Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy with High-Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis.

Tsuji H, Nakashima R, Hosono Y, Imura Y, Yagita M, Yoshifuji H, Hirata S, Nojima T, Sugiyama E, Hatta K, Taguchi Y, Katayama M, Tanizawa K, Handa T, Uozumi R, Akizuki S, Murakami K, Hashimoto M, Tanaka M, Ohmura K, Mimori T.

Arthritis Rheumatol. 2019 Sep 16. doi: 10.1002/art.41105. [Epub ahead of print]

PMID:
31524333
4.

Compression scheme of electro-holography based on the vector quantization of point light sources.

Nishitsuji T, Hosono Y, Kakue T, Shimobaba T, Ito T, Asaka T.

Opt Express. 2019 Apr 15;27(8):11594-11607. doi: 10.1364/OE.27.011594.

PMID:
31053002
5.

Serum matrix metalloproteinase levels in polymyositis/dermatomyositis patients with interstitial lung disease.

Nakatsuka Y, Handa T, Nakashima R, Tanizawa K, Kubo T, Murase Y, Sokai A, Ikezoe K, Hosono Y, Watanabe K, Tokuda S, Uno K, Yoshizawa A, Tsuruyama T, Uozumi R, Nagai S, Hatta K, Taguchi Y, Mishima M, Chin K, Mimori T, Hirai T.

Rheumatology (Oxford). 2019 Mar 8. pii: kez065. doi: 10.1093/rheumatology/kez065. [Epub ahead of print]

PMID:
30851107
6.

Serum neopterin as well as ferritin, soluble interleukin-2 receptor, KL-6 and anti-MDA5 antibody titer provide markers of the response to therapy in patients with interstitial lung disease complicating anti-MDA5 antibody-positive dermatomyositis.

Nishioka A, Tsunoda S, Abe T, Yoshikawa T, Takata M, Kitano M, Matsui K, Nakashima R, Hosono Y, Ohmura K, Mimori T, Sano H.

Mod Rheumatol. 2019 Sep;29(5):814-820. doi: 10.1080/14397595.2018.1548918. Epub 2019 Feb 7.

PMID:
30449228
7.

Improvement of exertional dyspnea and breathing pattern of inspiration to expiration after bronchial thermoplasty.

Miki K, Miki M, Yoshimura K, Tsujino K, Kagawa H, Oshitani Y, Ohara Y, Hosono Y, Edahiro R, Kurebe H, Kitada S.

Allergy Asthma Clin Immunol. 2018 Oct 29;14:74. doi: 10.1186/s13223-018-0276-3. eCollection 2018.

8.

[Analysis of Neoadjuvant Chemotherapy for HER2-Positive Breast Cancer in Our Department].

Nakada T, Hosono Y.

Gan To Kagaku Ryoho. 2018 Oct;45(10):1504-1506. Japanese.

PMID:
30382059
9.

Three Cases of Idiopathic Diffuse Pulmonary Ossification.

Edahiro R, Kurebe H, Nakatsubo S, Hosono Y, Sawa N, Nishida K, Ohara Y, Oshitani Y, Kagawa H, Tsujino K, Yoshimura K, Miki K, Miki M, Kitada S, Mori M.

Intern Med. 2019 Feb 15;58(4):545-551. doi: 10.2169/internalmedicine.0929-18. Epub 2018 Oct 17.

10.

Post-progression survival after cessation of treatment with nivolumab for advanced non-small cell lung cancer: A retrospective study.

Yano Y, Kurebe H, Edahiro R, Hosono Y, Nakatsubo S, Nishida K, Sawa N, Ishijima M, Uenami T, Kanazu M, Akazawa Y, Yamaguchi T, Mori M.

PLoS One. 2018 Aug 28;13(8):e0203070. doi: 10.1371/journal.pone.0203070. eCollection 2018.

11.

Increased Synthesis of MCL-1 Protein Underlies Initial Survival of EGFR-Mutant Lung Cancer to EGFR Inhibitors and Provides a Novel Drug Target.

Song KA, Hosono Y, Turner C, Jacob S, Lochmann TL, Murakami Y, Patel NU, Ham J, Hu B, Powell KM, Coon CM, Windle BE, Oya Y, Koblinski JE, Harada H, Leverson JD, Souers AJ, Hata AN, Boikos S, Yatabe Y, Ebi H, Faber AC.

Clin Cancer Res. 2018 Nov 15;24(22):5658-5672. doi: 10.1158/1078-0432.CCR-18-0304. Epub 2018 Aug 7.

PMID:
30087143
12.

Recurrence of anti-MDA5 antibody-positive clinically amyopathic dermatomyositis after long-term remission: A case report.

Endo Y, Koga T, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Umeda M, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kuwana M, Hosono Y, Mimori T, Kawakami A.

Medicine (Baltimore). 2018 Jun;97(26):e11024. doi: 10.1097/MD.0000000000011024.

13.

Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression.

Zhang Y, Pitchiaya S, Cieślik M, Niknafs YS, Tien JC, Hosono Y, Iyer MK, Yazdani S, Subramaniam S, Shukla SK, Jiang X, Wang L, Liu TY, Uhl M, Gawronski AR, Qiao Y, Xiao L, Dhanasekaran SM, Juckette KM, Kunju LP, Cao X, Patel U, Batish M, Shukla GC, Paulsen MT, Ljungman M, Jiang H, Mehra R, Backofen R, Sahinalp CS, Freier SM, Watt AT, Guo S, Wei JT, Feng FY, Malik R, Chinnaiyan AM.

Nat Genet. 2018 Jun;50(6):814-824. doi: 10.1038/s41588-018-0120-1. Epub 2018 May 28.

14.

Febrile neutropenia with bacterial paronychia.

Hosono Y, Uenami T, Yano Y, Mori M.

Clin Case Rep. 2018 Jan 26;6(3):543-544. doi: 10.1002/ccr3.1399. eCollection 2018 Mar.

15.

[Evaluation of Body Temperature during Pancreaticoduodenectomy for Pancreatic Cancer in Elderly Patients Aged over 75 Years Old].

Aoyama T, Hosono Y, Ikumi N, Ota Y, Ito M, Ishii F, Kishi H, Murakawa M, Atsumi Y, Kazama K, Rino Y, Masuda M, Morinaga S.

Gan To Kagaku Ryoho. 2018 Feb;45(2):282-284. Japanese.

PMID:
29483421
16.

[A case of anti-PL-7 antibody positive polymyositis with thrombotic microangiopathy].

Tamura M, Kitano M, Azuma K, Tsuboi K, Abe T, Ogita C, Yokoyama Y, Furukawa T, Yoshikawa T, Saito A, Nishioka A, Sekiguchi M, Azuma N, Tsunoda S, Hosono Y, Nakashima R, Ohmura K, Matsui K, Mimori T, Sano H.

Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(6):450-455. doi: 10.2177/jsci.40.450. Japanese.

17.

The association between erythromycin monotherapy for Mycobacterium avium complex lung disease and cross-resistance to clarithromycin: A retrospective case-series study.

Hosono Y, Kitada S, Yano Y, Mori M, Miki K, Miki M, Yoshimura K, Kagawa H, Oshitani Y, Yokota S.

J Infect Chemother. 2018 May;24(5):353-357. doi: 10.1016/j.jiac.2017.12.008. Epub 2018 Feb 1.

PMID:
29361415
18.

Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis.

Kochi Y, Kamatani Y, Kondo Y, Suzuki A, Kawakami E, Hiwa R, Momozawa Y, Fujimoto M, Jinnin M, Tanaka Y, Kanda T, Cooper RG, Chinoy H, Rothwell S, Lamb JA, Vencovský J, Mann H, Ohmura K, Myouzen K, Ishigaki K, Nakashima R, Hosono Y, Tsuboi H, Kawasumi H, Iwasaki Y, Kajiyama H, Horita T, Ogawa-Momohara M, Takamura A, Tsunoda S, Shimizu J, Fujio K, Amano H, Mimori A, Kawakami A, Umehara H, Takeuchi T, Sano H, Muro Y, Atsumi T, Mimura T, Kawaguchi Y, Mimori T, Takahashi A, Kubo M, Kohsaka H, Sumida T, Yamamoto K.

Ann Rheum Dis. 2018 Apr;77(4):602-611. doi: 10.1136/annrheumdis-2017-212149. Epub 2018 Jan 13.

PMID:
29331962
19.

Isolation of a peptide containing d-amino acid residues that inhibits the α-helix-mediated p53-MDM2 interaction from a one-bead one-compound library.

Morimoto J, Hosono Y, Sando S.

Bioorg Med Chem Lett. 2018 Feb 1;28(3):231-234. doi: 10.1016/j.bmcl.2018.01.001. Epub 2018 Jan 2.

PMID:
29326019
20.

Exercise tolerance and balance of inspiratory-to-expiratory muscle strength in relation to breathing timing in patients with chronic obstructive pulmonary disease.

Miki K, Tsujino K, Edahiro R, Kitada S, Miki M, Yoshimura K, Kagawa H, Oshitani Y, Ohara Y, Hosono Y, Kurebe H, Maekura R.

J Breath Res. 2018 Mar 28;12(3):036008. doi: 10.1088/1752-7163/aaa6db.

PMID:
29321341
21.

Radiation Pneumonitis with Eosinophilic Alveolitis in a Lung Cancer Patient.

Hosono Y, Sawa N, Nakatsubo S, Ishijima M, Uenami T, Kanazu M, Akazawa Y, Yano Y, Mori M, Yamaguchi T, Yokota S.

Intern Med. 2018 May 1;57(9):1281-1285. doi: 10.2169/internalmedicine.9338-17. Epub 2017 Dec 27.

22.

Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA.

Hosono Y, Niknafs YS, Prensner JR, Iyer MK, Dhanasekaran SM, Mehra R, Pitchiaya S, Tien J, Escara-Wilke J, Poliakov A, Chu SC, Saleh S, Sankar K, Su F, Guo S, Qiao Y, Freier SM, Bui HH, Cao X, Malik R, Johnson TM, Beer DG, Feng FY, Zhou W, Chinnaiyan AM.

Cell. 2017 Dec 14;171(7):1559-1572.e20. doi: 10.1016/j.cell.2017.11.040.

23.

Case series of pleomorphic carcinomas of the lung treated with nivolumab.

Kanazu M, Uenami T, Yano Y, Nakatsubo S, Hosono Y, Ishijima M, Akazawa Y, Yamaguchi T, Urasaki K, Mori M, Yokota S.

Thorac Cancer. 2017 Nov;8(6):724-728. doi: 10.1111/1759-7714.12505. Epub 2017 Sep 7.

24.

Inactivating mutations and hypermethylation of the NKX2-1/TTF-1 gene in non-terminal respiratory unit-type lung adenocarcinomas.

Matsubara D, Soda M, Yoshimoto T, Amano Y, Sakuma Y, Yamato A, Ueno T, Kojima S, Shibano T, Hosono Y, Kawazu M, Yamashita Y, Endo S, Hagiwara K, Fukayama M, Takahashi T, Mano H, Niki T.

Cancer Sci. 2017 Sep;108(9):1888-1896. doi: 10.1111/cas.13313. Epub 2017 Jul 29.

25.

Vitiligo in a patient with lung adenocarcinoma treated with nivolumab: A case report.

Uenami T, Hosono Y, Ishijima M, Kanazu M, Akazawa Y, Yano Y, Mori M, Yamaguchi T, Yokota S.

Lung Cancer. 2017 Jul;109:42-44. doi: 10.1016/j.lungcan.2017.04.019. Epub 2017 Apr 27.

PMID:
28577948
26.

The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.

Tanizawa K, Handa T, Nakashima R, Kubo T, Hosono Y, Watanabe K, Aihara K, Ikezoe K, Sokai A, Nakatsuka Y, Taguchi Y, Hatta K, Noma S, Kobashi Y, Yoshizawa A, Oga T, Hirai T, Chin K, Nagai S, Izumi T, Mimori T, Mishima M.

Respir Med. 2017 Jun;127:57-64. doi: 10.1016/j.rmed.2017.04.007. Epub 2017 Apr 15.

27.

A case of anti-aminoacyl tRNA synthetase antibody syndrome complicated by hemophagocytic syndrome.

Azuma K, Tamura M, Kurajoh M, Hosono Y, Nakajima R, Tsuboi K, Abe T, Ogita C, Yokoyama Y, Furukawa T, Yoshikawa T, Saito A, Nishioka A, Sekiguchi M, Azuma N, Kitano M, Tsunoda S, Omura K, Koyama H, Matsui K, Mimori T, Sano H.

Nihon Rinsho Meneki Gakkai Kaishi. 2016;39(6):538-544. doi: 10.2177/jsci.39.538. Review. Japanese.

28.

Splicing factor proline/glutamine-rich is a novel autoantigen of dermatomyositis and associated with anti-melanoma differentiation-associated gene 5 antibody.

Hosono Y, Nakashima R, Serada S, Murakami K, Imura Y, Yoshifuji H, Ohmura K, Naka T, Mimori T.

J Autoimmun. 2017 Feb;77:116-122. doi: 10.1016/j.jaut.2016.11.006. Epub 2016 Dec 3.

PMID:
27919567
29.

Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.

Hozumi H, Fujisawa T, Nakashima R, Johkoh T, Sumikawa H, Murakami A, Enomoto N, Inui N, Nakamura Y, Hosono Y, Imura Y, Mimori T, Suda T.

Respir Med. 2016 Dec;121:91-99. doi: 10.1016/j.rmed.2016.10.019. Epub 2016 Nov 2.

30.

The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression.

Niknafs YS, Han S, Ma T, Speers C, Zhang C, Wilder-Romans K, Iyer MK, Pitchiaya S, Malik R, Hosono Y, Prensner JR, Poliakov A, Singhal U, Xiao L, Kregel S, Siebenaler RF, Zhao SG, Uhl M, Gawronski A, Hayes DF, Pierce LJ, Cao X, Collins C, Backofen R, Sahinalp CS, Rae JM, Chinnaiyan AM, Feng FY.

Nat Commun. 2016 Sep 26;7:12791. doi: 10.1038/ncomms12791.

31.

Blood-borne miRNA profile-based diagnostic classifier for lung adenocarcinoma.

Tai MC, Yanagisawa K, Nakatochi M, Hotta N, Hosono Y, Kawaguchi K, Naito M, Taniguchi H, Wakai K, Yokoi K, Takahashi T.

Sci Rep. 2016 Aug 10;6:31389. doi: 10.1038/srep31389.

32.

Anti-TIF1-γ antibody and cancer-associated myositis: A clinicohistopathologic study.

Hida A, Yamashita T, Hosono Y, Inoue M, Kaida K, Kadoya M, Miwa Y, Yajima N, Maezawa R, Arai S, Kurasawa K, Ito K, Shimada H, Iwanami T, Sonoo M, Hatanaka Y, Murayama S, Uchibori A, Chiba A, Aizawa H, Momoo T, Nakae Y, Sakurai Y, Shiio Y, Hashida H, Yoshizawa T, Sakiyama Y, Oda A, Inoue K, Takeuchi S, Iwata NK, Date H, Masuda N, Mikata T, Motoyoshi Y, Uesaka Y, Maeda MH, Nakashima R, Tsuji S, Kwak S, Mimori T, Shimizu J.

Neurology. 2016 Jul 19;87(3):299-308. doi: 10.1212/WNL.0000000000002863. Epub 2016 Jun 24.

PMID:
27343066
33.

Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease.

Nakashima R, Hosono Y, Mimori T.

Lupus. 2016 Jul;25(8):925-33. doi: 10.1177/0961203316651748. Review.

PMID:
27252271
34.

Reliability and clinical utility of Enzyme-linked immunosorbent assay for detection of anti-aminoacyl-tRNA synthetase antibody.

Abe T, Tsunoda S, Nishioka A, Azuma K, Tsuboi K, Ogita C, Yokoyama Y, Furukawa T, Maruoka M, Tamura M, Yoshikawa T, Saito A, Sekiguchi M, Azuma N, Kitano M, Matsui K, Hosono Y, Nakashima R, Ohmura K, Mimori T, Sano H.

Nihon Rinsho Meneki Gakkai Kaishi. 2016;39(2):140-4. doi: 10.2177/jsci.39.140. Japanese.

35.

KRAS Engages AGO2 to Enhance Cellular Transformation.

Shankar S, Pitchiaya S, Malik R, Kothari V, Hosono Y, Yocum AK, Gundlapalli H, White Y, Firestone A, Cao X, Dhanasekaran SM, Stuckey JA, Bollag G, Shannon K, Walter NG, Kumar-Sinha C, Chinnaiyan AM.

Cell Rep. 2016 Feb 16;14(6):1448-1461. doi: 10.1016/j.celrep.2016.01.034. Epub 2016 Feb 4.

36.

[Autoantibodies in myositis].

Mimori T, Hosono Y, Nakashima R.

Nihon Rinsho. 2015 Sep;73 Suppl 7:554-60. Japanese. No abstract available.

PMID:
26480758
37.

Diagnostic relevance of autoantibody detection against inhibitors of apoptosis proteins in colon cancer and colon adenoma.

Hosono Y, Goto M, Kobayashi D, Kuribayashi K, Tanaka M, Watanabe N.

Mol Clin Oncol. 2015 May;3(3):595-600. Epub 2015 Feb 6.

38.

Screening for IgG4-type anti-nuclear antibodies in IgG4-related disease.

Kiyama K, Yoshifuji H, Kandou T, Hosono Y, Kitagori K, Nakashima R, Imura Y, Yukawa N, Ohmura K, Fujii T, Kawabata D, Mimori T.

BMC Musculoskelet Disord. 2015 May 28;16:129. doi: 10.1186/s12891-015-0584-4.

39.

Anti-PM/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma.

Muro Y, Hosono Y, Sugiura K, Ogawa Y, Mimori T, Akiyama M.

Arthritis Res Ther. 2015 Mar 11;17:57. doi: 10.1186/s13075-015-0573-x.

40.

Juvenile polymyositis associated with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibody in a 13-year-old girl.

Hamada M, Tanaka I, Sakurai Y, Hosono Y, Mimori T.

Mod Rheumatol. 2017 May;27(3):541-544. doi: 10.3109/14397595.2015.1014137. Epub 2015 Mar 12.

PMID:
25698369
41.

The landscape of long noncoding RNAs in the human transcriptome.

Iyer MK, Niknafs YS, Malik R, Singhal U, Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, Poliakov A, Cao X, Dhanasekaran SM, Wu YM, Robinson DR, Beer DG, Feng FY, Iyer HK, Chinnaiyan AM.

Nat Genet. 2015 Mar;47(3):199-208. doi: 10.1038/ng.3192. Epub 2015 Jan 19.

42.

Early pulmonary involvement of anti-CADM-140 autoantibody-positive rapidly progressive interstitial lung disease preceding typical cutaneous symptoms.

Tamai K, Tachikawa R, Otsuka K, Ueda H, Hosono Y, Tomii K.

Intern Med. 2014;53(21):2515-9. Epub 2014 Nov 1.

43.

Antitumor necrosis factor alpha inhibitor-induced dermatomyositis and interstitial lung disease with anti-PL12 autoantibody: signs of antisynthetase syndrome.

Kato M, Oiso N, Nozaki Y, Inoue A, Hosono Y, Funauchi M, Mimori T, Matsumura I, Kawada A.

J Dermatol. 2014 Nov;41(11):1034-6. doi: 10.1111/1346-8138.12626. Epub 2014 Oct 8. No abstract available.

PMID:
25294403
44.

The effect of competition on the neutral intraspecific diversity of invasive species.

Roques L, Hosono Y, Bonnefon O, Boivin T.

J Math Biol. 2015 Aug;71(2):465-89. doi: 10.1007/s00285-014-0825-4. Epub 2014 Sep 6.

PMID:
25193551
45.

Autoantibodies to DNA mismatch repair enzymes in polymyositis/dermatomyositis and other autoimmune diseases: a possible marker of favorable prognosis.

Muro Y, Nakashima R, Hosono Y, Sugiura K, Mimori T, Akiyama M.

Arthritis Rheumatol. 2014 Dec;66(12):3457-62.

46.

Proteomic identification of heterogeneous nuclear ribonucleoprotein K as a novel cold-associated autoantigen in patients with secondary Raynaud's phenomenon.

Yang L, Fujimoto M, Murota H, Serada S, Fujimoto M, Honda H, Yamada K, Suzuki K, Nishikawa A, Hosono Y, Yoneda Y, Takehara K, Imura Y, Mimori T, Takeuchi T, Katayama I, Naka T.

Rheumatology (Oxford). 2015 Feb;54(2):349-58. doi: 10.1093/rheumatology/keu325. Epub 2014 Aug 28.

PMID:
25172934
47.

Amyopathic dermatomyositis complicated with eosinophilic pneumonia.

Iijima Y, Furusawa H, Tateishi T, Tsuchiya K, Fujie T, Tamaoka M, Sakashita H, Miyazaki Y, Sumi Y, Hosono Y, Nakashima R, Mimori T, Inase N.

Intern Med. 2014;53(14):1539-44. Epub 2014 Jul 15.

48.

Anxiety affects the amplitudes of red and green color-elicited flash visual evoked potentials in humans.

Hosono Y, Kitaoka K, Urushihara R, Séi H, Kinouchi Y.

J Med Invest. 2014;61(1-2):79-83.

49.

Tipin functions in the protection against topoisomerase I inhibitor.

Hosono Y, Abe T, Higuchi M, Kajii K, Sakuraba S, Tada S, Enomoto T, Seki M.

J Biol Chem. 2014 Apr 18;289(16):11374-84. doi: 10.1074/jbc.M113.531707. Epub 2014 Feb 25.

50.

The multicenter study of a new assay for simultaneous detection of multiple anti-aminoacyl-tRNA synthetases in myositis and interstitial pneumonia.

Nakashima R, Imura Y, Hosono Y, Seto M, Murakami A, Watanabe K, Handa T, Mishima M, Hirakata M, Takeuchi T, Fujio K, Yamamoto K, Kohsaka H, Takasaki Y, Enomoto N, Suda T, Chida K, Hisata S, Nukiwa T, Mimori T.

PLoS One. 2014 Jan 14;9(1):e85062. doi: 10.1371/journal.pone.0085062. eCollection 2014.

Supplemental Content

Loading ...
Support Center